Evome Medical Technologies, Inc. Finite-lived Intangible Assets Acquired
Evome Medical Technologies, Inc. reported Finite-lived Intangible Assets Acquired of CAD 0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Notes
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2024-04-16
- Evome Medical Technologies, Inc. finite-lived intangible assets acquired for the quarter ending 2023-12-31 was 0.00 CAD, a 100.00% decline year-over-year.
- Evome Medical Technologies, Inc. finite-lived intangible assets acquired for the quarter ending 2023-09-30 was 0.00 CAD, a 100.00% decline year-over-year.
- Evome Medical Technologies, Inc. finite-lived intangible assets acquired for the quarter ending 2023-06-30 was 0.00 CAD.
- Evome Medical Technologies, Inc. finite-lived intangible assets acquired for the quarter ending 2023-03-31 was 0.00 CAD.
- Evome Medical Technologies, Inc. finite-lived intangible assets acquired for fiscal 2023 was 0.00 CAD.
- Evome Medical Technologies, Inc. finite-lived intangible assets acquired for fiscal 2022 was 0.00 CAD.
| Period end | Finite-lived Intangible Assets Acquired 0 month | Finite-lived Intangible Assets Acquired 3 month | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 9 month | Finite-lived Intangible Assets Acquired 10 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | 0.00 CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 0.00 CAD derived: sum of 2 quarters · filed 2024-04-16 | 0.00 CAD derived: sum of 3 quarters · filed 2024-04-16 | 0.00 CAD 10-K · filed 2024-04-16 | ||
| 2023-09-30 | 0.00 CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 0.00 CAD derived: sum of 2 quarters · filed 2023-11-14 | 0.00 CAD 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | 0.00 CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 0.00 CAD 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 0.00 CAD 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | 243.20K CAD 10-K · filed 2024-04-16 | |||||
| 2022-11-30 | 35.67K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17 | 278.20K CAD derived: sum of 2 quarters · filed 2023-01-17 | 278.20K CAD 10-Q · filed 2023-01-17 | 278.20K CAD derived: sum of 4 quarters · filed 2023-01-17 | ||
| 2022-08-31 | 242.53K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17 | 242.53K CAD 10-Q · filed 2022-10-17 | 242.53K CAD derived: sum of 3 quarters · filed 2022-10-17 | 242.53K CAD derived: sum of 4 quarters · filed 2022-10-17 | ||
| 2022-05-31 | 0.00 CAD 10-Q · filed 2022-07-15 | 0.00 CAD derived: sum of 2 quarters · filed 2022-07-15 | 0.00 CAD derived: sum of 3 quarters · filed 2022-07-15 | 0.00 CAD derived: sum of 4 quarters · filed 2022-07-15 | ||
| 2022-02-28 | 0.00 CAD derived: 10-K 9 month − 10-Q 6 month · filed 2022-05-31 | 0.00 CAD derived: sum of 2 quarters · filed 2022-05-31 | 0.00 CAD 10-K · filed 2022-05-31 | 0.00 CAD 10-KT · filed 2023-04-03 | ||
| 2021-12-31 | 0.00 CAD 10-KT · filed 2023-04-03 | |||||
| 2021-11-30 | 0.00 CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-14 | 0.00 CAD 10-Q · filed 2022-01-14 | ||||
| 2021-08-31 | 0.00 CAD 10-Q · filed 2021-10-15 | |||||
| 2021-05-31 | 0.00 CAD 10-Q/A · filed 2021-08-02 |